Dr. Rodney Yeates - Publications

  1. Artemotil Artecef, R. A. Yeates Current Opinion in Investigational Drugs (2002) 3, 545-549

  2. Fluconazole penetration into the pancreas, S. Shrikande, H. Friess, C. Issenegger, M. E. Martignoni, H. Yong, B. Gloor, R. Yeates, J. Kleef, M.W. Buchler, Antimicrob Agents Chemother(2000) 44, 2569-2571

  3. The pharmacokinetics of extended-release formulations of calcium antagonists and of amlodipine in subjects with different gastrointestinal transit times, T. Zimmermann, H. Laufen, R. Yeates, F. Scharpf, K.-D. Riedel, T. Schumacher, J Clin Pharmacol (1999) 39, 1021-1031

  4. The uptake of fluconazole in finger and toe nails, H. Laufen, T. Zimmermann, R. A. Yeates, T. Schumacher, A. Wildfeuer, Int J Clin Pharmacol Ther (1999) 37, 352-360

  5. Accumulation of fluconazole in scalp hair, R. A. Yeates, H. Laufen, T. Zimmermann, F.Scharpf, J. Clin.Pharmacol. (1998) 38, 138-143

  6. Fluconazole concentrations in pulmonary tissue and pericardial fluid, C. M.Rieder-Nelissen, J. Hasse, R. A. Yeates, E. Sarnow, Infection (1997) 25, 192-194

  7. Fluconazole: review of tissue pharmacokinetics and in vitro activity, A. Wildfeuer, H.Laufen, A.-F. Schmalreck, R.A. Yeates, T. Zimmermann, Mycoses (1997) 40, 259-265

  8. Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility of yeasts, A. Wildfeuer, H. Laufen, A.-F. Schmalreck, R.A. Yeates, T. Zimmermann, Mycoses (1996) 39 (S2), 51-57

  9. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin, R.A. Yeates, H. Laufen, T. Zimmermann, T. Schumacher. Int. J. Clin. Pharm. Ther. (1997) 35, 577-579

  10. Screening for cytochrome P450 3A in man: studies with midazolam and nifedipine, R. A. Yeates, F.Scharpf, H.Laufen, T. Zimmermann. J. Pharm. Pharmacol. (1996) 48, 933-934

  11. Interaction between midazolam and clarithromycin: comparison with azithromycin, R. A. Yeates, H. Laufen, T. Zimmermann, Int. J. Clin. Pharm. Ther. (1996) 34, 400-405

  12. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam, T. Zimmermann, R. A. Yeates, H. Laufen, A. Wildfeuer. Drug Res. (1996) 46, 213-217

  13. A new pharmaceutical concept for the treatment of oropharangeal and oesophageal candidosis with fluconazole, A. Wildfeuer, H. Laufen, R. A. Yeates, Mycoses (1996) 39 (S1), 123-126

  14. Comparative pharmacokinetics of fluconazole and itraconazole in Japanese and in German subjects, R. A. Yeates, T. Zimmermann, H. Laufen, A. Wildfeuer, Int J Clin Pharm Ther (1995) 32, 131-135

  15. Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole. Studies with a suspension, H. Laufen, R. A. Yeates, T. Zimmermann, C. de los Reyes, Drugs Exptl Clin Res (1995) 21, 23-28

  16. Single-dose pharmacokinetics of fluconazole in patients with , M. Ruhnke, R. A. Yeates, M. Sarnow, G. Pfaff, A. Hartmann, G. Trautmann, J Antimicrob Chemother (1995) 35, 641-647

  17. Influence of doxazosin on the activity of the endothelium-derived relaxing factor, R. A. Yeates, Drug Res (1994) 44, 1117-1121

  18. The influence of gastric pH on the pharmacokinetics of fluconazole: the effect of omeprazole, T. Zimmermann, R. A. Yeates, K. Riedel, P. Lach, H. Laufen, Int J Clin Pharm Ther (1994) 32, 491-496

  19. The pharmacokinetics of fluconazole after a single intravenous dose in AIDS patients, R. A. Yeates, M. Ruhnke, G. Pfaff, M. Trautmann, A. Hartmann, Br J Clin Pharmacol (1994) 38, 77-79

  20. The influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole, T. Zimmermann, R. A. Yeates, H. Laufen, Eur J Clin Pharmacol (1994) 46, 147-150

  21. The influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects, T. Zimmermann, R. A. Yeates, M. Albrecht, H. Laufen, Int J Clin Pharm Ther (1994) 14, 87-93

  22. Administration of the antimycotic agents fluconazole and itraconazole to leukaemia patients: a comparative pharmacokinetic study, S. Lazo de Vega, P.Volkow, R. A. Yeates, G. Pfaff, Drugs Exptl Clin Res (1994) 20, 69-75

  23. The pharmacokinetics of fluconazole after a single intravenous dose in AIDS patients, R. A. Yeates, M. Ruhnke, G. Pfaff AIDS (1994) 8, 16

  24. Pharmacokinetics and tolerance of fluconazole suppositories in healthy volunteers, G. Pfaff, T. Zimmermann, R. A. Yeates, Drug Res (1993) 43, 391-395

  25. Single dose intravenous pharmacokinetics of fluconazole in infants, I. Krzeska, R. A. Yeates, G. Pfaff, Drugs Clin Exptl Clin Res (1993) 19, 267-271

  26. Total prevention of the development of in vitro tolerance to organic nitrates, R. A. Yeates, M. Schmid, Drug Res (1992) 42, 297-302

  27. Relative bioavailability of sultamicillin in healthy volunteers following administration of Two tablet formulations, A. Wildfeuer, T. Zimmermann, R. A. Yeates, H. Laufen, J Int Med Res (1992) 20, 4A-11A

  28. Possible mechanisms of activation of soluble guanylate cyclase by organic nitrates, R. A. Yeates, Drug Res (1992) 42, 297-302

  29. Comparison of isobutyl nitrate and isobutyl nitrite: tolerance and crosstolerance to glyceryl trinitrate, T. Zimmermann, M. Leitold, R. A. Yeates, Eur J Pharmacol (1991)192, 181-184

  30. Pharmacokinetic profile of fluconazole, a systemic antimycotic, A. Wildfeuer, T. Zimmermann, R. A. Yeates, Med Welt (1991) 42, 436-440

  31. Antagonism of glycerol trinitrate activity by an inhibitor of glutathione-S-transferase, R. A. Yeates, M. Schmid, M. Leitold, Biochem Pharmacol (1989) 38, 1749-1753

  32. Gas chromatographic assay of glycerol mononitrates in biological samples, F. Scharpf, R. A. Yeates, H.Laufen, G. Eibel, J Chromatog (1987) 413, 91-99

  33. Studies on the pharmacology and pharmacokinetics of glycerol-2-nitrate, M. Leitold, H.Laufen, R. A. Yeates, Drug Res (1987) 37, 692-698

  34. Hypotensive, anti-anginal activity of glycerol-1-nitrate in the rat and in the dog, M. Leitold, H. Laufen, R. A. Yeates, Drug Res (1986) 36, 1577-1582

  35. Pharmacokinetics of oral doses of glycerol-1-nitrate, H. Laufen, R. A. Yeates, M. Leitold Eur J Clin Pharmacol (1986) 31, 169-175

  36. A preliminary study of the pharmacokinetics of desmethyldiazepam administered as drops or tablets, R. A. Yeates, H. Laufen, K. Räder, M. Leitold, Drug Res (1986) 36, 138-140

  37. The reaction between organic nitrates and sulphydryl compounds, R. A. Yeates, H. Laufen, M. Leitold, Mol Pharmacol (1985) 28, 555-559

  38. Ultrastructural damage of in vitro cultures of ookinetes of Plasmodium gallinaceum (Brumpt) by purified proteinases of susceptible Aedes aegypti (L.), Z.Parasitenkunde (1981) 66, 93-97

  39. The mosquito Aedes aegypti (L.): evidence for three new proteinases, R. A. Yeates Z. Parasitenkunde (1980) 61, 277-286

  40. In vitro damage of cultured ookinetes of Plasmodium gallinaceum by digestive proteinases from susceptible Aedes aegypti, R. F. Gass, R. A. Yeates, Acta Tropica (1979) 36, 243-252

  41. Proteinases of female Aedes aegypti (L.), R. A. Yeates, Acta Tropica (1978) 35, 195-196

  42. Measurement of anti-enzyme antibodies using an active-site directed radiolabel, R. A. Yeates, B. M. Ogilvie, J Immunol Methods (1976) 12, 57-65

  43. Nematode acetylcholinesterases, R. A. Yeates, B. M. Ogilvie in Biochemistry of Parasites and Host-Parasite Relationships, ed. H. van den Bossche (1975) 307-310

  44. Antibody responses in self-infections with Necator americanus, B. M. Ogilvie, A. Bartlett, R. C. Godfrey, J. A. Turton, M. J. Worms, R. A. Yeates, Trans Roy Soc Trop Hyg Med (1978) 72, 66-71

  45. Interaction of beef-heart mitochondrial ATPase, coupling factor F1, with aurovertin, R. A. Yeates, BBA (1974) 333, 173-179

  46. Induction of conformational changes in bovine . R. A. Yeates, BBA (1974) 334, 45-57

  47. Induction of conformational changes in bovine . R. A. Yeates, BBA (1974) 334, 58-74